argia.eus
INPRIMATU
Difficulties in implementing the second dose of AstraZeneca vaccine cause discomfort among the population
  • Representatives of the Basque Government and the Government of Navarra are now asking patients to have administered the first dose of AstraZeneca Pfizer vaccine. Among the workers and professionals under the age of 60 who took this dose, there is a concern and indignation that show that they feel "as if they did something wrong".
Urko Apaolaza Avila @urkoapaolaza 2021eko maiatzaren 27a
Iñigo Urkulluk ere Astrazenecaren dosia jarri nahi dutenei arazoak izango dituztela iradoki die (irudia: EiTB)

Thousands of people have been affected in recent days by the decision of the regional institutions on the vaccine. Many workers under the age of 60 (teachers, pharmacists...) received the first Astrazeneca vaccine, but now in the second they are being asked to take it from Pfizer. If they want to pass through Astrazeneca, they have been warned that they will be placed on the waiting list and that they "cannot guarantee" that they will be placed within 12 weeks. In addition, they must sign an authorization for the placement of this vaccine and fill out an online form to make the request.

Thus, compared to the facilities for the establishment of Pfizer, those interested in putting Astrazeneca have found only contradictory problems and messages from the authorities. Naiz Irratia gathers the opinions of some of these professionals: "It's not normal, it looks like we're doing something suspicious," says a professor. "Why do we have to sign AstraZeneca as if we were doing something dangerous? ", explained another.

For its part, the ELA union has denounced that the management of the Basque Government in the second dose of the vaccine against Covid-19 is being "chaotic": "Behind the administration of the second dose of workers under 60 years of age we are not clear whether there are scientific criteria or supply problems."

In fact, many of those who are waiting for the vaccine believe that the supply problems are hindering the second placement of Astrazeneca by the Government of Navarra and the CAPV, and not because there is sufficient scientific evidence of the damage, at least more than what may arise in the mixture of Astrazeneca and Pfizer: "Why do they treat us as children? If there is a supply problem, let them tell you.

The Spanish Government has announced that 1.3 million doses of Astrazeneca will shortly reach the Spanish State, which could be sufficient to meet the demand. However, lehendakari, Iñigo Urkullu, has responded immediately by saying that what was promised and what was actually acquired are not often the same, that it is not certain that those doses will arrive. And the message again in the same direction and in the same tone: Those who want an Astrazeneca "have no choice but to wait," the director explained.